SMPDB ID,Pathway Name,Pathway Subject,Metabolite ID,Metabolite Name,HMDB ID,KEGG ID,ChEBI ID,DrugBank ID,CAS,Formula,IUPAC,SMILES,InChI,InChI Key
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C008817,Lidocaine,HMDB0014426,C07073,6456,DB00281,137-58-6,C14H22N2O,"2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide",CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",NNJVILVZKWQKPM-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040580,"2,6-Dimethylaniline",HMDB0060677,C11004,28738,,87-62-7,C8H11N,"2,6-dimethylaniline",CC1=CC=CC(C)=C1N,"InChI=1S/C8H11N/c1-6-4-3-5-7(2)8(6)9/h3-5H,9H2,1-2H3",UFFBMTHBGFGIHF-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040578,Monoethylglycinexylidide,HMDB0060656,C16561,222828,,7728-40-7,C12H18N2O,"N-(2,6-dimethylphenyl)-2-(ethylamino)acetamide",CCNCC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15)",WRMRXPASUROZGT-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040576,3-Hydroxylidocaine,HMDB0060655,C16560,,,34604-55-2,C14H22N2O2,"2-(diethylamino)-N-(3-hydroxy-2,6-dimethylphenyl)acetamide",CCN(CC)CC(=O)NC1=C(C)C=CC(O)=C1C,"InChI=1S/C14H22N2O2/c1-5-16(6-2)9-13(18)15-14-10(3)7-8-12(17)11(14)4/h7-8,17H,5-6,9H2,1-4H3,(H,15,18)",PMGUCIDDSCRAMY-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040577,3-Hydroxymonoethylglycinexylidide,HMDB0060678,C16572,,,34604-56-3,C12H18N2O2,"2-(ethylamino)-N-(3-hydroxy-2,6-dimethylphenyl)acetamide",CCNCC(=O)NC1=C(C)C=CC(O)=C1C,"InChI=1S/C12H18N2O2/c1-4-13-7-11(16)14-12-8(2)5-6-10(15)9(12)3/h5-6,13,15H,4,7H2,1-3H3,(H,14,16)",YITCMQBVWIHTTA-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040579,Glycinexylidide,HMDB0060679,C16569,357241,,18865-38-8,C10H14N2O,"2-amino-N-(2,6-dimethylphenyl)acetamide",CC1=CC=CC(C)=C1NC(=O)CN,"InChI=1S/C10H14N2O/c1-7-4-3-5-8(2)10(7)12-9(13)6-11/h3-5H,6,11H2,1-2H3,(H,12,13)",IXYVBZOSGGJWCW-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040581,2-Amino-3-methylbenzoate,HMDB0060680,C16571,,,4389-45-1,C8H9NO2,2-amino-3-methylbenzoic acid,CC1=C(N)C(=CC=C1)C(O)=O,"InChI=1S/C8H9NO2/c1-5-3-2-4-6(7(5)9)8(10)11/h2-4H,9H2,1H3,(H,10,11)",WNAJXPYVTFYEST-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040582,"4-Hydroxy-2,6-dimethylaniline",HMDB0060681,C16570,55545,,3096-70-6,C8H11NO,"4-amino-3,5-dimethylphenol",CC1=CC(O)=CC(C)=C1N,"InChI=1S/C8H11NO/c1-5-3-7(10)4-6(2)8(5)9/h3-4,10H,9H2,1-2H3",GCWYXRHXGLFVFE-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C001065,Oxygen,HMDB0001377,C00007,15379,,7782-44-7,O2,oxidanone,O=O,InChI=1S/O2/c1-2,MYMOFIZGZYHOMD-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C000146,NADPH,HMDB0000221,C00005,16474,"",53-57-6,C21H30N7O17P3,"{[(2S,3S,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-[({[({[(2S,3R,4S,5S)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-4-hydroxyoxolan-3-yl]oxy}phosphonic acid",NC(=O)C1=CN(C=CC1)[C@H]1O[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](OP(O)(O)=O)[C@H]2O)N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m0/s1",ACFIXJIJDZMPPO-NCHANQSKSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C040034,Hydrogen Ion,HMDB0059597,C00080,15378,,,H,hydron,[H+],InChI=1S/p+1,GPRLSGONYQIRFK-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C001420,Water,HMDB0002111,C00001,15377,,7732-18-5,H2O,water,O,InChI=1S/H2O/h1H2,XLYOFNOQVPJJNP-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C000143,NADP,HMDB0000217,C00006,18009,,53-59-8,C21H29N7O17P3,"1-[(2R,3R,4S,5R)-5-[({[({[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",XJLXINKUBYWONI-NNYOXOHSSA-O
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C001799,Heme,HMDB0003178,C00032,17627,DB02577,14875-96-8,C34H32FeN4O4,"(1R)-15,19-bis(2-carboxyethyl)-5,10-diethenyl-4,9,14,20-tetramethyl-2λ⁵,22,23λ⁵,25-tetraaza-1-ferraoctacyclo[11.9.1.1¹,⁸.1³,²¹.0²,⁶.0¹⁶,²³.0¹⁸,²².0¹¹,²⁵]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)",CC1=C(CCC(O)=O)C2=CC3=[N+]4C(=CC5=C(C=C)C(C)=C6C=C7C(C=C)=C(C)C8=[N+]7[Fe@]4(N2C1=C8)N56)C(C)=C3CCC(O)=O,"InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+4/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;",YHLKGEDAGPGZPN-RGGAHWMASA-L
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C001144,NADH,HMDB0001487,C00004,16908,DB00157,58-68-4,C21H29N7O14P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,"InChI=1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",BOPGDPNILDQYTO-NNYOXOHSSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C001102,Formaldehyde,HMDB0001426,C00067,16842,DB03843,50-00-0,CH2O,formaldehyde,C=O,InChI=1S/CH2O/c1-2/h1H2,WSFSSNUMVMOOMR-UHFFFAOYSA-N
SMP0000620,Lidocaine (Local Anaesthetic) Metabolism Pathway,Drug Metabolism,PW_C000721,NAD,HMDB0000902,C00003,15846,,53-84-9,C21H28N7O14P2,"1-[(2R,3R,4S,5R)-5-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",BAWFJGJZGIEFAR-NNYOXOHSSA-O
